MBX Biosciences' corporate headquarters is located at:
11711 N. Meridian Street, Suite 300
Carmel, IN 46032
Where is the company incorporated?
MBX Biosciences’ is incorporated in the state of Delaware.
When did MBX Biosciences go public?
The initial public offering (IPO) occurred on September 13, 2024.
What is MBX Biosciences' fiscal year end?
The fiscal year end is December 31.
How is MBX Biosciences stock traded?
MBX Biosciences is traded on the NASDAQ Global Select Market under the ticker symbol “MBX”.
Does MBX Biosciences pay dividends?
No, MBX Biosciences does not pay a dividend.
Who is MBX Biosciences' transfer agent?
The transfer agent and registrar for the common stock is Computershare Trust Company, N.A. The transfer agent and registrar’s address is 150 Royall Street, Canton, MA 02021.
Who is MBX Biosciences' independent auditor?
MBX Biosciences’ independent registered public accounting firm is Ernst & Young LLP.
Who is MBX Biosciences' legal counsel?
MBX Biosciences’ legal counsel is Goodwin Procter LLP.
How can I view documents MBX Biosciences has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
SEC filings can be found at on our SEC Filings page and on the SEC website.
Whom should I contact regarding investor inquiries?
Additional investor queries can be directed to MBX Biosciences by contacting investors@mbxbio.com.
